These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24919218)

  • 1. [Advancement of researches on association of non-alcoholic fatty liver disease with type 2 diabetes mellitus].
    Gao X; Wang S
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):161-4. PubMed ID: 24919218
    [No Abstract]   [Full Text] [Related]  

  • 2. Interfering parameters in nonalcoholic fatty liver disease fibrosis score.
    Sertoglu E; Kayadibi H; Uyanik M
    Liver Int; 2015 Jan; 35(1):285. PubMed ID: 25102955
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease and diabetes.
    Reyes-García R; Rozas-Moreno P; Llamoza-Torres CJ; Mezquita-Raya P
    Med Clin (Barc); 2017 Jan; 148(1):33-38. PubMed ID: 27751514
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonalcoholic steatohepatitis and diabetes.
    Caballeria J; Caballeria L
    Endocrinol Nutr; 2016 Oct; 63(8):377-9. PubMed ID: 27423933
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to Dr. Sertoglu and colleagues.
    Petta S; Vanni E; Craxì A
    Liver Int; 2015 Jan; 35(1):285-6. PubMed ID: 25131005
    [No Abstract]   [Full Text] [Related]  

  • 7. A Study of Non?Alcoholic Fatty Liver Disease in Type II Diabetes.
    Hussain MA; Prahlad B; Fazullulah S
    J Assoc Physicians India; 2020 Jan; 68(1):90. PubMed ID: 31979848
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of antidiabetic drugs in patients with non-alcoholic fatty liver disease].
    Yang G; Yuan L
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):174-7. PubMed ID: 24919223
    [No Abstract]   [Full Text] [Related]  

  • 9. Astaxanthin Improves Nonalcoholic Fatty Liver Disease in Werner Syndrome with Diabetes Mellitus.
    Takemoto M; Yamaga M; Furuichi Y; Yokote K
    J Am Geriatr Soc; 2015 Jun; 63(6):1271-3. PubMed ID: 26096415
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of ferritin and hepcidin with disease severity in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus.
    Cravo C; Villela-Nogueira CA; Cardoso AC; Perez RM; Leite NC
    Liver Int; 2023 Nov; 43(11):2571-2575. PubMed ID: 37752888
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter regarding 'Association of thyroid function with non-alcoholic fatty liver disease in recent-onset diabetes'.
    Hsiao RC; Liaw YP
    Liver Int; 2024 Feb; 44(2):629. PubMed ID: 38196380
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease in patients with type 2 diabetes: diagnostic and therapeutic considerations.
    Paraschou EM; Shalit A; Paschou SA
    Hormones (Athens); 2024 Sep; 23(3):415-417. PubMed ID: 38093156
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-alcoholic steatohepatitis in type 2 diabetes mellitus.
    Gupte P; Amarapurkar D; Agal S; Baijal R; Kulshrestha P; Pramanik S; Patel N; Madan A; Amarapurkar A; Hafeezunnisa
    J Gastroenterol Hepatol; 2004 Aug; 19(8):854-8. PubMed ID: 15242486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-alcoholic fatty liver disease in type 2 diabetes: a joint statement of the Chilean Hepatology and Diabetology Societies].
    Arab JP; Castro L; Gómez PC; Vignolo P; Arrese M; Barrera F; Castro F; Díaz LA; Donoso A; Elgueta K; González K; González MI; Moreno M; Lazarte R; Poniachik J; Salman P; Valderas JP
    Rev Med Chil; 2021 Sep; 149(9):1360-1371. PubMed ID: 35319691
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of non alcoholic fatty liver disease and associated factors?
    Moran S
    Ann Hepatol; 2022; 27(2):100659. PubMed ID: 35007769
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver-heart connection in diabetes mellitus.
    Yip TC; Wong VW; Wong GL
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1385-1386. PubMed ID: 34105827
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: III. Relation with Type II diabetes: regulation by hepatokines].
    Misu H
    Nihon Naika Gakkai Zasshi; 2016 Jan; 105(1):25-30. PubMed ID: 27266040
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?
    Williams DM; Krishnamoorthy SV; Ch'ng CL; Stephens JW; Min T
    Obesity (Silver Spring); 2022 May; 30(5):969-970. PubMed ID: 35373513
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to: "Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?".
    Barb D; Cusi K
    Obesity (Silver Spring); 2022 May; 30(5):971-972. PubMed ID: 35394120
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver steatosis linked to type 2 diabetes outcomes.
    Bhala N
    BMJ; 2024 Feb; 384():q309. PubMed ID: 38350679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.